GENFIT Launches a Phase 2 Trial Evaluating Elafibranor on Hepatic Lipid Composition for NAFL — Study objective to determine the effect of elafibranor, a dual PPAR alpha/delta agonist, on fatty acid saturation — Phase 2 study to evaluate the effect of a...
CyMedica launches new study to evaluate the effectiveness of e-vive™ for reducing pain and improving function by increasing quadriceps strength in patients with knee osteoarthritis CyMedica Orthopedics®, the leading combined digital health and muscle strengthening...
New York Times bestselling author Kurt Eichenwald will be at Crowne Plaza Houston Near Reliant Medical on Thursday, June 13, at 7 p.m. to discuss his 2018 memoir, “A Mind Unraveled,” in which he details his personal battle with epilepsy. The free event is at the...
– MOMENTUM Phase 3 clinical trial planned for launch in Q4 2019; topline efficacy data anticipated in Q4 2021 –- World renowned myelofibrosis expert Dr. Srdan Verstovsek named Chief Investigator of the MOMENTUM Phase 3 study — 180 patient 2:1 randomized,...
Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma MELBOURNE, Australia, June 04, 2019 (GLOBE NEWSWIRE) — Aravax, a clinical stage biotechnology company focused on developing the first safe and rapidly...
Results, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, demonstrated clinically meaningful response in patients with urothelial carcinoma whose treatment previously failed, a population with high unmet medical need...
Email
Text